

(Alliance News) - DCC PLC on Tuesday maintained that it has made "significant progress" in financial 2026, though surging exceptional costs weighed on...


(Alliance News) - Dr Martens PLC on Tuesday reported a sharp rise in annual profit but said there is still "work to do" in pivoting the business and i...


(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday:


(Sharecast News) - IG Group surged on Tuesday as the online trading provider lifted its guidance for 2026 and its medium-term outlook following a stro...


(Alliance News) - IG Group Holdings PLC shares climbed on Tuesday as it upgraded its guidance and reported strong first quarter revenue growth as it a...


(Alliance News) - European stocks traded higher on Tuesday morning, with the mood lifted by Middle East peace talk hope, while the pound was back belo...


(Alliance News) - Standard Chartered set out new growth targets and announces a plan to cut some 15% of its corporate functions roles by 2030. Diploma...


SINGAPORE, May 19 (Reuters) - HSBC Holdings has raised A$1.4 billion ($1 billion) from a three-part Australian dollar bond sale on Tuesday after inv...


(Alliance News) - The FTSE 100 closed higher on Monday, recouping most of Friday's hefty falls, amid a calmer bond market and as Iran responded to the...


* Changes could provide up to 80 billion pounds more in business lending


(Alliance News) - Manx Financial Group PLC on Monday reported net asset value growth but lower profit for 2025, and pencilled in the launch of its ove...


(Sharecast News) - The UK is poised to loosen rules introduced in the wake of the financial crisis requiring banks to ring-fence their retail arms, it...


LONDON, May 18 (Reuters) - A rush of foreign bids for UK companies has put Britain on track to outstrip all previous records for dealmaking in 2026...


(Alliance News) - European stocks were mixed on Monday afternoon, with the FTSE 100 outperforming, as US-Iran tensions and tepid China data keep a lid...


(Sharecast News) - Analysts at Citi have reiterated a 'buy' rating on AstraZeneca and a 'neutral' on GSK following the European pharma sector's first-...